The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy of abiraterone acetate (AA) in patients aged 75 or more with metastatic castration-resistant prostate cancer (mCRPC) in both pre-chemotherapy or post-chemotherapy settings: Real-life experience from thirteen Italian centers.
 
Zuzana Sirotova
No Relationships to Disclose
 
Giulia Courthod
No Relationships to Disclose
 
Alfredo Tartarone
No Relationships to Disclose
 
Orazio Caffo
Honoraria - Astellas Pharma; Bayer; Janssen Oncology; Sanofi
 
Francesca Maines
No Relationships to Disclose
 
Maurizio Bertuccelli
No Relationships to Disclose
 
Franco Morelli
No Relationships to Disclose
 
Gianmauro Numico
No Relationships to Disclose
 
Pamela Guglielmini
No Relationships to Disclose
 
Giuseppe Fornarini
No Relationships to Disclose
 
Veronica Prati
No Relationships to Disclose
 
Erica Palesandro
No Relationships to Disclose
 
Cinzia Ortega
No Relationships to Disclose
 
Alessandra Mosca
No Relationships to Disclose
 
Stefania Miraglia
No Relationships to Disclose
 
Valentina Perrone
No Relationships to Disclose
 
Elena Fea
No Relationships to Disclose
 
Giacomo Allegrini
No Relationships to Disclose
 
Alessandro Mozzicafreddo
No Relationships to Disclose
 
Marina Schena
No Relationships to Disclose